You need to enable JavaScript to run this app.
For 2024 data, please check our new website (in development)
VIEW
Global Database for Tracking Antimicrobial Resistance (AMR)
Country Self- Assessment Survey (TrACSS)
Choose your question and filters:
Survey year
2023
2022
2021
2020
2019
2018
2017
Question
All questions
2.1 Multi-sector and One Health collaboration/coordination
2.2.1 Which sectors are actively involved in [Human Health]
2.2.2 Which sectors are actively involved in [Terrestrial animal health]
2.2.3 Which sectors are actively involved in [Aquatic animal heath]
2.2.4 Which sectors are actively involved in [Plant Health]
2.2.5 Which sectors are actively involved in [Food Production]
2.2.6 Which sectors are actively involved in [Food Safety]
2.2.7 Which sectors are actively involved in [Environment]
2.2.8 Which sectors are actively involved in [Other]
2.3 Country progress with development of a national action plan on AMR
2.3.a If the national AMR plan has/or is about to expire, is the country in the process of revising the national AMR action plan or developing a new one?
2.3.b Does the country have a monitoring and evaluation plan for the national AMR action plan?
2.3.c Is there a focal point or specific working group responsible for the monitoring and evaluation of the implementation of the national AMR action plan?
2.3.d Is data for the indicators as defined in the monitoring and evaluation plan for the national AMR action plan collected regularly across all relevant sectors?
2.3.e Do you have adequate technical capacity, resources and established systems in the country to collect data across all relevant sectors?
2.3.f Are relevant data disaggregated by sex, geographic location, income, etc.?
2.3.g Is the data analysed and used by the AMR multisector coordination mechanism for decision making across all relevant sectors and to advocate for policy changes and allocation of adequate resources?
2.4.a Does the multisector coordination mechanism meet to discuss the response to the TrACSS questionnaire before submission?
2.4.b Does the multisector coordination mechanism review current and previous year data from TrACSS as a way to monitor progress of AMR national action plan implementation?
2.6 Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets?
2.6.a Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [One Health Strategy or One Health mechanism]
2.6.b Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [Water, Sanitation and Hygiene (WASH)]
2.6.c Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [National health sector plan]
2.6.d Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [National action plan on health security]
2.6.e Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [Climate change and environmental planning]
2.6.f Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [National development plans; United Nations Sustainable Development Coorporation Framework (UNSDCF)]
2.6.g Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [National Food Safety strategy and policies]
2.6.h Is your country’s national action planning on AMR integrated with other existing action plans or, strategies or targets? [National Agriculture development plans and policies]
2.7.1 COVID-19 Impact on AMR National Action Plan implementation: No impact
2.7.2 COVID-19 Impact on AMR National Action Plan implementation: Positive impact
2.7.3 COVID-19 Impact on AMR National Action Plan implementation: Negative governance and administrative impact
2.7.4 COVID-19 Impact on AMR National Action Plan implementation: Negative Operational impact
2.8.1 Country has laws or regulations on prescription and sale of antimicrobials, for human use.
2.8.2 Country has laws or regulations on prescription and sale of antimicrobials for terrestrial animal use.
2.8.3 Country has laws or regulations on prescription and sale of antimicrobials for aquatic animals.
2.8.4 Country has laws or regulations on prescription and sale of medicated feed .
2.8.5 Country has laws or regulations that prohibits the use of antibiotics for growth promotion in terrestrial animals in the absence of risk analysis.
2.8.6 Country has legislation on the registration and use of applicable pesticides with antimicrobial effects, such as bactericides and fungicides used in plant production.
2.9 Raising awareness and understanding of AMR risks and response
2.9.1.a For the level selected above, please indicate the extent of involvement of the sectors below. [Human Health]
2.9.1.b For the level selected above, please indicate the extent of involvement of the sectors below. [Terrestrial Animal Health]
2.9.1.c For the level selected above, please indicate the extent of involvement of the sectors below. [Aquatic Animal Health]
2.9.1.d For the level selected above, please indicate the extent of involvement of the sectors below. [Plant Health]
2.9.1.e For the level selected above, please indicate the extent of involvement of the sectors below. [Food Production]
2.9.1.f For the level selected above, please indicate the extent of involvement of the sectors below. [Food Safety]
2.9.1.g For the level selected above, please indicate the extent of involvement of the sectors below. [Environment]
2.10 Do school-going children and youth (primary and secondary) receive education on antimicrobial resistance, as a long-term investment in mitigating AMR?
2.11 Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies
2.11.a Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies [Human Health]
2.11.b Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies [Terrestrial Animal Health]
2.11.c Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies [Aquatic Animal Health]
2.11.d Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies [Plant Health]
2.11.e Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies [Food Production]
2.11.f Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies [Food Safety]
2.11.g Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies [Environment]
2.12 Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies
2.12.a Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies [Human Health]
2.12.b Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies [Terrestrial Animal Health]
2.12.c Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies [Aquatic Animal Health]
2.12.d Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies [Plant Health]
2.12.e Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies [Food Production]
2.12.f Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies [Food Safety]
2.12.g Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies [Environment]
2.13 Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance
2.13.a Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance [Human Health]
2.13.b Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance [Terrestrial Animal Health]
2.13.c Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance [Aquatic Animal Health]
2.13.d Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance [Plant Health]
2.13.e Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance [Food Production]
2.13.f Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance [Food Safety]
2.13.g Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance [Environment]
3.1 Training and professional education on AMR in the human health sector
3.2 National monitoring system for consumption and rational use of antimicrobials in human health
3.3 National surveillance system for antimicrobial resistance (AMR) in humans
3.4.2 Does the country have one or more reference labs performing AST/susceptibility testing for the following 11 bacteria
3.4.2.a Does the country have one or more reference lab/s performing [Acinetobacter baumannii]
3.4.2.b Does the country have one or more reference lab/s performing [Pseudomonas aeruginosa]
3.4.2.c Does the country have one or more reference lab/s performing [Enterobacteriaceae E.coli, Klebsiella, Proteus]
3.4.2.d Does the country have one or more reference lab/s performing [Enterococcus faecium]
3.4.2.e Does the country have one or more reference lab/s performing [Staphylococcus aureus]
3.4.2.f Does the country have one or more reference lab/s performing [Campylobacter spp]
3.4.2.g Does the country have one or more reference lab/s performing [Salmonellae]
3.4.2.h Does the country have one or more reference lab/s performing [Neisseria gonorrhoeae]
3.4.2.i Does the country have one or more reference lab/s performing [Streptococcus pneumoniae]
3.4.2.j Does the country have one or more reference lab/s performing [Haemophilus influenzae]
3.4.2.k Does the country have one or more reference lab/s performing [Shigella spp]
3.4.3 Does the country have one or more National Mycology Reference Laboratory designated by ministry of health to perform identification AND susceptibility testing of Candida and Aspergillus?
3.4.5 In your country, is there a mechanism in place to report stock-outs of reagents/consumables for the diagnosis of bacterial infections and AST in clinical bacteriology laboratories in the public health sector?
3.4.6 Are standardized national or international AST guidelines used by the National Reference Bacteriology/AST Laboratory (NRBL) and by clinical bacteriology laboratories at all levels of the public health system?
3.4.7 Does the country have an external quality assurance EQA programme and to what extent it is implemented?
3.4.8 Does the country have developed a national list of essential in-vitro diagnostics that includes all essential AMR diagnostics?
3.5 Infection Prevention and Control (IPC) in human health care
3.6 Optimizing antimicrobial use in human health
3.7 Adoption of “AWaRe” classification of antibiotics in the National Essential Medicines List
4.1 Training and professional education on AMR in the veterinary sector
4.2 Training and professional education on AMR in the aquatic animal health sector
4.3 Progress with strengthening veterinary services
4.4 Progress with strengthening aquatic animal health services
4.5.a Do you have a national plan or system in place for monitoring sales/use of antimicrobials in animals?
4.5.b Do you submit AMU data to the WOAH Database on Antimicrobial agents?
4.6 WOAH Reporting Options for the antimicrobial use database
4.7 National surveillance system for antimicrobial resistance (AMR) in live terrestrial animals
4.7.1.a AMR surveillance is routinely undertaken in live terrestrial animals for the following categories: [Terrestrial animal isolates linked to animal disease.]
4.7.1.b AMR surveillance is routinely undertaken in live terrestrial animals for the following categories: [Zoonotic pathogenic bacteria (e.g. Salmonella spp. in terrestrial animals)]
4.7.1.c AMR surveillance is routinely undertaken in live terrestrial animals for the following categories: [Commensal isolates (e.g. E. coli for terrestrial animals)]
4.7.1.d AMR surveillance is routinely undertaken in live terrestrial animals for the following categories: [Specific resistance phenotypes (e.g. ESBL producing indicator E. coli obtained from healthy animals in key food producing species). Please specify below]
4.8 National surveillance system for antimicrobial resistance (AMR) in live aquatic animals
4.8.1.a AMR surveillance is routinely undertaken in live aquatic animals for the following categories [Aquatic animal isolates linked to animal disease (e.g. Aeromonas spp.).]
4.8.1.b AMR surveillance is routinely undertaken in live aquatic animals for the following categories [Zoonotic pathogenic bacteria (e.g. Vibrio parahaemolyticus)]
4.8.1.c AMR surveillance is routinely undertaken in live aquatic animals for the following categories [Commensal isolates (e.g. non-pathogenic Aeromonas hydrophila)]
4.9 Biosecurity and good animal husbandry practices to reduce the use of antimicrobials and minimize development and transmission of AMR in terrestrial animal production
4.10 Biosecurity and good animal husbandry practices to reduce the use of antimicrobials and minimize development and transmission of AMR in aquatic animal production
4.11 Optimizing antimicrobial use in terrestrial animal health
4.12 Optimizing antimicrobial use in aquatic animal health
5.1 Training and professional education on AMR provided to the agriculture (animal and plant), food production, food safety and the environment sectors
5.2 National monitoring system for antimicrobial- pesticide use in plant production including bactericides and fungicides
5.3 National surveillance system for antimicrobial resistance (AMR) in food (terrestrial and aquatic animal and plant origin)
5.3.1.a AMR surveillance is systematically undertaken in food (terrestrial and aquatic animal and plant origin) in the following categories (A Food borne pathogenic bacteria (e.g. Salmonella spp., Campylobacter spp.) [Terrestrial animal origin])
5.3.1.b AMR surveillance is systematically undertaken in food (terrestrial and aquatic animal and plant origin) in the following categories (A Food borne pathogenic bacteria (e.g. Salmonella spp., Campylobacter spp.) [Aquatic animal origin])
5.3.1.c AMR surveillance is systematically undertaken in food (terrestrial and aquatic animal and plant origin) in the following categories (A Food borne pathogenic bacteria (e.g. Salmonella spp., Campylobacter spp.) [Plant origin])
5.3.1.d AMR surveillance is systematically undertaken in food (terrestrial and aquatic animal and plant origin) in the following categories (B Indicator bacteria (e.g. E.coli, Enterococcus spp.) [Terrestrial animal origin])
5.3.1.e AMR surveillance is systematically undertaken in food (terrestrial and aquatic animal and plant origin) in the following categories (B Indicator bacteria (e.g. E.coli, Enterococcus spp.) [Aquatic animal origin])
5.3.1.f AMR surveillance is systematically undertaken in food (terrestrial and aquatic animal and plant origin) in the following categories (B Indicator bacteria (e.g. E.coli, Enterococcus spp.) [Plant origin])
5.4.a Effective integration of laboratories in the AMR surveillance in the animal health and food safety sectors
5.4.b Level of the standardization and harmonization of procedures among laboratories included in the AMR surveillance system in the animal health and food safety sectors
5.4.c Relevance of diagnostic (bacteriology) techniques used by laboratories included in the AMR surveillance system in the animal health and food safety sectors
5.4.d Technical level of data management of the laboratory network in the AMR surveillance system in the animal health and food safety sectors
5.5 Good manufacturing and hygiene practices to reduce the development and transmission of AMR in food processing
5.6 Optimizing antimicrobial pesticide such as bactericides and fungicides use in plant production
6.1 Has a national assessment of risks for residues of antimicrobial compounds and antimicrobial resistant pathogens in the environment been conducted?
6.1.1 Have risk assessments been conducted? Human sewage treatment quality (including lack of basic toilets, and management of wastewater and sludge collected in sewer networks and onsite facilities such as septic tanks).
6.1.2 Have risk assessments been conducted? Wastewater discharges from health facilities for disposal in the environment (including lack of basic toilets and management of wastewater and sludge collected in sewer networks and from onsite sanitation such as septic tanks).
6.1.3 Have risk assessments been conducted? Management of solid clinical waste from health facilities to be destroyed by incineration.
6.1.4 Have risk assessments been conducted? Disposal of medicines, antimicrobial agents (unused, left-over product and also product containers) for human use
6.1.5 Have risk assessments been conducted? Disposal of medicines, antimicrobial agents (unused, left-over product and/or also product containers) for animal use
6.1.6 Have risk assessments been conducted? Discharges from intensive terrestrial animal production (liquid and/or solid waste)
6.1.7 Have risk assessments been conducted? Discharges from intensive aquatic animal production (liquid and solid waste)
6.1.8 Have risk assessments been conducted? Wastewater discharges from manufacturing sites for antimicrobial agents (either as Active Pharmaceutical Ingredient (API) or finished products).
6.1.9 Have risk assessments been conducted? Disposal of food, plant or animal products contaminated with antimicrobial residues over the MRL (maximum residue limit)
6.1.10 Have risk assessments been conducted? Runoff and solid waste from slaughterhouses (abattoirs), traditional markets and food processing plants
6.1.11 Have risk assessments been conducted? Liquid and solid waste from intensive terrestrial animal production prior to use in agriculture
6.1.12 Have risk assessments been conducted? Liquid and solid waste from intensive aquatic animal production prior to use in agriculture
6.1.13 Have risk assessments been conducted? Human solid waste that may be used for agricultural purposes
6.1.14 Have risk assessments been conducted? Overspray, drift, and leaching following pesticide applications
6.1.15 Have risk assessments been conducted? Dust, drift, and leaching following fertilizer applications
6.1.16 Have risk assessments been conducted? Transnational and intercontinental transport and movement of food, goods, live animals and people
6.1.17 Have risk assessments been conducted? Storm runoff, wastewater treatment plant overflow or failure (in case of severe weather and flooding events)
6.2 Country has legislation and/or regulations to prevent contamination of the environment with antimicrobials- antimicrobial compounds and their metabolites discharged to the environment
6.2.1 Are there legislation and/or regulation and policies to mitigate risks? Human sewage treatment quality (including lack of basic toilets, and management of wastewater and sludge collected in sewer networks and onsite facilities such as septic tanks)
6.2.2 Are there legislation and/or regulation and policies to mitigate risks? Wastewater discharges from health facilities for disposal in the environment (including lack of basic toilets and management of wastewater and sludge collected in sewer networks and from onsite sanitation such as septic tanks).
6.2.3 Are there legislation and/or regulation and policies to mitigate risks? Management of solid clinical waste from health facilities to be destroyed by incineration.
6.2.4 Are there legislation and/or regulation and policies to mitigate risks? Disposal of medicines, antimicrobial agents (unused, left-over product and also product containers) for human use.
6.2.5 Are there legislation and/or regulation and policies to mitigate risks? Disposal of medicines, antimicrobial agents (unused, left-over product and/or also product containers) for animal use.
6.2.6 Are there legislation and/or regulation and policies to mitigate risks? Discharges from intensive terrestrial animal production (liquid and/or solid waste).
6.2.7 Are there legislation and/or regulation and policies to mitigate risks? Discharges from intensive aquatic animal production (liquid and solid waste).
6.2.8 Are there legislation and/or regulation and policies to mitigate risks? Wastewater discharges from manufacturing sites for antimicrobial agents (either as Active Pharmaceutical Ingredient (API) or finished products).
6.2.9 Are there legislation and/or regulation and policies to mitigate risks? Disposal of food, plant or animal products contaminated with antimicrobial residues over the MRL (maximum residue limit).
6.2.10 Are there legislation and/or regulation and policies to mitigate risks? Runoff and solid waste from slaughterhouses (abattoirs), traditional markets and food processing plants.
6.2.11 Are there legislation and/or regulation and policies to mitigate risks? Liquid and solid waste from intensive terrestrial animal production prior to use in agriculture.
6.2.12 Are there legislation and/or regulation and policies to mitigate risks? Liquid and solid waste from intensive aquatic animal production prior to use in agriculture.
6.2.13 Are there legislation and/or regulation and policies to mitigate risks? Human solid waste that may be used for agricultural purposes.
6.2.14 Are there legislation and/or regulation and policies to mitigate risks? Overspray, drift, and leaching following pesticide applications.
6.2.15 Are there legislation and/or regulation and policies to mitigate risks? Dust, drift, and leaching following fertilizer applications.
6.2.16 Are there legislation and/or regulation and policies to mitigate risks? Transnational and intercontinental transport and movement of food, goods, live animals and people.
6.2.17 Are there legislation and/or regulation and policies to mitigate risks? Storm runoff, wastewater treatment plant overflow or failure (in case of severe weather and flooding events).
6.3 Is there a system for regular monitoring (passive surveillance) of antimicrobial compounds and their metabolites (or residues) and resistant bacteria or antimicrobial resistance genes (ARGs) in water quality
WHO
FAO
WOAH
Income
WHO Region
All
AFR
AMER
EMR
EUR
SEAR
WPR
Country
All
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Venezuela (Bolivarian Republic of)
Bolivian (Plurinational State of)
Bosnia and Herzegovina
Botswana
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Central African Republic
Chad
Chile
People 's Republic of China
Colombia
Comoros
Democratic Republic of the Congo
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Cyprus
Czechia
Democratic People's Republic of Korea
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea - Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan (Kyrgyz Republic)
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Lithuania
Luxembourg
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands (Kingdom of)
New Zealand
Nicaragua
Niger
Nigeria
Niue
North Macedonia
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Republic of Korea
Republic of Moldova
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia (Slovak Republic)
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syrian Arab Republic
Tajikistan
Thailand
Timor - Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Türkiye
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Norhern Ireland
United Republic of Tanzania
United States of America
Uruguay
Uzbekistan
Vanuatu
Viet Nam
Yemen
Zambia
Zimbabwe
Map View
Visualization View
Table View
Response Overview
Country Reports
Download Responses
Print
,